DrugPatentWatch Database Preview
Drugs in Development Information for Phenylacetic acid
Development status for investigational drug Phenylacetic acid: Patents, clinical trial progress, indications
Phenylacetic acid is an investigational drug.
There have been 4 clinical trials for Phenylacetic acid.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2017.
The most common disease conditions in clinical trials are Urea Cycle Disorders, Inborn, Disease, and Drug-Related Side Effects and Adverse Reactions. The leading clinical trial sponsors are Shijiazhuang Yiling Pharmaceutical Co. Ltd, Horizon Therapeutics, LLC, and Yiling Pharmaceutical Inc.
There are three US patents protecting this investigational drug and forty-one international patents.
Summary for Phenylacetic acid
| US Patents | 3,016 |
| International Patents | 41,363 |
| US Patent Applications | 3,827 |
| WIPO Patent Applications | 1,930 |
| Japanese Patent Applications | 6 |
| Clinical Trial Progress | Phase 1 (2017-11-01) |
| Vendors | 48 |
Recent Clinical Trials for Phenylacetic acid
| Title | Sponsor | Phase |
|---|---|---|
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China | Shijiazhuang Yiling Pharmaceutical Co. Ltd | Phase 1 |
| Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders | Horizon Therapeutics, LLC | Phase 4 |
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China | Yiling Pharmaceutical Inc. | Phase 1 |
Clinical Trial Summary for Phenylacetic acid
Top disease conditions for Phenylacetic acid
Top clinical trial sponsors for Phenylacetic acid
US Patents for Phenylacetic acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Phenylacetic acid | Start Trial | Method of diagnosing and treating cancer using B-catenin splice variants | The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) | Start Trial |
| Phenylacetic acid | Start Trial | 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists | Bristol-Myers Squibb Company (Princeton, NJ) | Start Trial |
| Phenylacetic acid | Start Trial | Fused heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Phenylacetic acid | Start Trial | Pyrrolidine amide compounds as histone demethylase inhibitors | GENENTECH, INC. (South San Francisco, CA) CONSTELLATION PHARMACEUTICALS INC. (Cambridge, MA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Phenylacetic acid
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Phenylacetic acid | Australia | 2006213610 | 2025-02-10 | Start Trial |
| Phenylacetic acid | Canada | 2596845 | 2025-02-10 | Start Trial |
| Phenylacetic acid | Denmark | 1851340 | 2025-02-10 | Start Trial |
| Phenylacetic acid | European Patent Office | 1851340 | 2025-02-10 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
